This report contains market size and forecasts of CRISPR Gene Testing and Diagnostics in Global, including the following market information:
Global CRISPR Gene Testing and Diagnostics Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global CRISPR Gene Testing and Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Animals Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of CRISPR Gene Testing and Diagnostics include 10x Genomics, Aelian Biotechnology, Agilent Technologies, Axxam, Beckman Coulter, Becton, Dickinson and Company, Binx Health, bioM?rieux and Bio-Rad Laboratories, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the CRISPR Gene Testing and Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CRISPR Gene Testing and Diagnostics Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global CRISPR Gene Testing and Diagnostics Market Segment Percentages, by Type, 2022 (%)
Animals
Plants
Pathogens
Others
Global CRISPR Gene Testing and Diagnostics Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global CRISPR Gene Testing and Diagnostics Market Segment Percentages, by Application, 2022 (%)
Medical Industry
Agriculture
Others
Global CRISPR Gene Testing and Diagnostics Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global CRISPR Gene Testing and Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CRISPR Gene Testing and Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CRISPR Gene Testing and Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
10x Genomics
Aelian Biotechnology
Agilent Technologies
Axxam
Beckman Coulter
Becton, Dickinson and Company
Binx Health
bioM?rieux
Bio-Rad Laboratories
Caspr Biotech
ERS Genomics
FASMAC
Illumina
Janssen Diagnostics
Locus Biosciences
Mammoth Biosciences
NRGene
Roche
Sherlock Biosciences
Thermo Fisher Scientific
Vivlion
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 CRISPR Gene Testing and Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CRISPR Gene Testing and Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CRISPR Gene Testing and Diagnostics Overall Market Size
2.1 Global CRISPR Gene Testing and Diagnostics Market Size: 2022 VS 2030
2.2 Global CRISPR Gene Testing and Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CRISPR Gene Testing and Diagnostics Players in Global Market
3.2 Top Global CRISPR Gene Testing and Diagnostics Companies Ranked by Revenue
3.3 Global CRISPR Gene Testing and Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 CRISPR Gene Testing and Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies CRISPR Gene Testing and Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 CRISPR Gene Testing and Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 CRISPR Gene Testing and Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 CRISPR Gene Testing and Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global CRISPR Gene Testing and Diagnostics Market Size Markets, 2022 & 2030
4.1.2 Animals
4.1.3 Plants
4.1.4 Pathogens
4.1.5 Others
4.2 By Type - Global CRISPR Gene Testing and Diagnostics Revenue & Forecasts
4.2.1 By Type - Global CRISPR Gene Testing and Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global CRISPR Gene Testing and Diagnostics Revenue, 2023-2030
4.2.3 By Type - Global CRISPR Gene Testing and Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CRISPR Gene Testing and Diagnostics Market Size, 2022 & 2030
5.1.2 Medical Industry
5.1.3 Agriculture
5.1.4 Others
5.2 By Application - Global CRISPR Gene Testing and Diagnostics Revenue & Forecasts
5.2.1 By Application - Global CRISPR Gene Testing and Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global CRISPR Gene Testing and Diagnostics Revenue, 2023-2030
5.2.3 By Application - Global CRISPR Gene Testing and Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global CRISPR Gene Testing and Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global CRISPR Gene Testing and Diagnostics Revenue & Forecasts
6.2.1 By Region - Global CRISPR Gene Testing and Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global CRISPR Gene Testing and Diagnostics Revenue, 2023-2030
6.2.3 By Region - Global CRISPR Gene Testing and Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America CRISPR Gene Testing and Diagnostics Revenue, 2018-2030
6.3.2 US CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.3.3 Canada CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.3.4 Mexico CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe CRISPR Gene Testing and Diagnostics Revenue, 2018-2030
6.4.2 Germany CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.4.3 France CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.4.4 U.K. CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.4.5 Italy CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.4.6 Russia CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.4.8 Benelux CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia CRISPR Gene Testing and Diagnostics Revenue, 2018-2030
6.5.2 China CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.5.3 Japan CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.5.4 South Korea CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.5.6 India CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America CRISPR Gene Testing and Diagnostics Revenue, 2018-2030
6.6.2 Brazil CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.6.3 Argentina CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CRISPR Gene Testing and Diagnostics Revenue, 2018-2030
6.7.2 Turkey CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.7.3 Israel CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
6.7.5 UAE CRISPR Gene Testing and Diagnostics Market Size, 2018-2030
7 Players Profiles
7.1 10x Genomics
7.1.1 10x Genomics Corporate Summary
7.1.2 10x Genomics Business Overview
7.1.3 10x Genomics CRISPR Gene Testing and Diagnostics Major Product Offerings
7.1.4 10x Genomics CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.1.5 10x Genomics Key News
7.2 Aelian Biotechnology
7.2.1 Aelian Biotechnology Corporate Summary
7.2.2 Aelian Biotechnology Business Overview
7.2.3 Aelian Biotechnology CRISPR Gene Testing and Diagnostics Major Product Offerings
7.2.4 Aelian Biotechnology CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Aelian Biotechnology Key News
7.3 Agilent Technologies
7.3.1 Agilent Technologies Corporate Summary
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies CRISPR Gene Testing and Diagnostics Major Product Offerings
7.3.4 Agilent Technologies CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Agilent Technologies Key News
7.4 Axxam
7.4.1 Axxam Corporate Summary
7.4.2 Axxam Business Overview
7.4.3 Axxam CRISPR Gene Testing and Diagnostics Major Product Offerings
7.4.4 Axxam CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Axxam Key News
7.5 Beckman Coulter
7.5.1 Beckman Coulter Corporate Summary
7.5.2 Beckman Coulter Business Overview
7.5.3 Beckman Coulter CRISPR Gene Testing and Diagnostics Major Product Offerings
7.5.4 Beckman Coulter CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Beckman Coulter Key News
7.6 Becton, Dickinson and Company
7.6.1 Becton, Dickinson and Company Corporate Summary
7.6.2 Becton, Dickinson and Company Business Overview
7.6.3 Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Major Product Offerings
7.6.4 Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Becton, Dickinson and Company Key News
7.7 Binx Health
7.7.1 Binx Health Corporate Summary
7.7.2 Binx Health Business Overview
7.7.3 Binx Health CRISPR Gene Testing and Diagnostics Major Product Offerings
7.7.4 Binx Health CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Binx Health Key News
7.8 bioM?rieux
7.8.1 bioM?rieux Corporate Summary
7.8.2 bioM?rieux Business Overview
7.8.3 bioM?rieux CRISPR Gene Testing and Diagnostics Major Product Offerings
7.8.4 bioM?rieux CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.8.5 bioM?rieux Key News
7.9 Bio-Rad Laboratories
7.9.1 Bio-Rad Laboratories Corporate Summary
7.9.2 Bio-Rad Laboratories Business Overview
7.9.3 Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Major Product Offerings
7.9.4 Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Bio-Rad Laboratories Key News
7.10 Caspr Biotech
7.10.1 Caspr Biotech Corporate Summary
7.10.2 Caspr Biotech Business Overview
7.10.3 Caspr Biotech CRISPR Gene Testing and Diagnostics Major Product Offerings
7.10.4 Caspr Biotech CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Caspr Biotech Key News
7.11 ERS Genomics
7.11.1 ERS Genomics Corporate Summary
7.11.2 ERS Genomics Business Overview
7.11.3 ERS Genomics CRISPR Gene Testing and Diagnostics Major Product Offerings
7.11.4 ERS Genomics CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.11.5 ERS Genomics Key News
7.12 FASMAC
7.12.1 FASMAC Corporate Summary
7.12.2 FASMAC Business Overview
7.12.3 FASMAC CRISPR Gene Testing and Diagnostics Major Product Offerings
7.12.4 FASMAC CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.12.5 FASMAC Key News
7.13 Illumina
7.13.1 Illumina Corporate Summary
7.13.2 Illumina Business Overview
7.13.3 Illumina CRISPR Gene Testing and Diagnostics Major Product Offerings
7.13.4 Illumina CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.13.5 Illumina Key News
7.14 Janssen Diagnostics
7.14.1 Janssen Diagnostics Corporate Summary
7.14.2 Janssen Diagnostics Business Overview
7.14.3 Janssen Diagnostics CRISPR Gene Testing and Diagnostics Major Product Offerings
7.14.4 Janssen Diagnostics CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.14.5 Janssen Diagnostics Key News
7.15 Locus Biosciences
7.15.1 Locus Biosciences Corporate Summary
7.15.2 Locus Biosciences Business Overview
7.15.3 Locus Biosciences CRISPR Gene Testing and Diagnostics Major Product Offerings
7.15.4 Locus Biosciences CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.15.5 Locus Biosciences Key News
7.16 Mammoth Biosciences
7.16.1 Mammoth Biosciences Corporate Summary
7.16.2 Mammoth Biosciences Business Overview
7.16.3 Mammoth Biosciences CRISPR Gene Testing and Diagnostics Major Product Offerings
7.16.4 Mammoth Biosciences CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.16.5 Mammoth Biosciences Key News
7.17 NRGene
7.17.1 NRGene Corporate Summary
7.17.2 NRGene Business Overview
7.17.3 NRGene CRISPR Gene Testing and Diagnostics Major Product Offerings
7.17.4 NRGene CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.17.5 NRGene Key News
7.18 Roche
7.18.1 Roche Corporate Summary
7.18.2 Roche Business Overview
7.18.3 Roche CRISPR Gene Testing and Diagnostics Major Product Offerings
7.18.4 Roche CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.18.5 Roche Key News
7.19 Sherlock Biosciences
7.19.1 Sherlock Biosciences Corporate Summary
7.19.2 Sherlock Biosciences Business Overview
7.19.3 Sherlock Biosciences CRISPR Gene Testing and Diagnostics Major Product Offerings
7.19.4 Sherlock Biosciences CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.19.5 Sherlock Biosciences Key News
7.20 Thermo Fisher Scientific
7.20.1 Thermo Fisher Scientific Corporate Summary
7.20.2 Thermo Fisher Scientific Business Overview
7.20.3 Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Major Product Offerings
7.20.4 Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.20.5 Thermo Fisher Scientific Key News
7.21 Vivlion
7.21.1 Vivlion Corporate Summary
7.21.2 Vivlion Business Overview
7.21.3 Vivlion CRISPR Gene Testing and Diagnostics Major Product Offerings
7.21.4 Vivlion CRISPR Gene Testing and Diagnostics Revenue in Global Market (2018-2023)
7.21.5 Vivlion Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. CRISPR Gene Testing and Diagnostics Market Opportunities & Trends in Global Market
Table 2. CRISPR Gene Testing and Diagnostics Market Drivers in Global Market
Table 3. CRISPR Gene Testing and Diagnostics Market Restraints in Global Market
Table 4. Key Players of CRISPR Gene Testing and Diagnostics in Global Market
Table 5. Top CRISPR Gene Testing and Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global CRISPR Gene Testing and Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global CRISPR Gene Testing and Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies CRISPR Gene Testing and Diagnostics Product Type
Table 9. List of Global Tier 1 CRISPR Gene Testing and Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CRISPR Gene Testing and Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - CRISPR Gene Testing and Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - CRISPR Gene Testing and Diagnostics Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - CRISPR Gene Testing and Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - CRISPR Gene Testing and Diagnostics Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2023-2030
Table 30. 10x Genomics Corporate Summary
Table 31. 10x Genomics CRISPR Gene Testing and Diagnostics Product Offerings
Table 32. 10x Genomics CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 33. Aelian Biotechnology Corporate Summary
Table 34. Aelian Biotechnology CRISPR Gene Testing and Diagnostics Product Offerings
Table 35. Aelian Biotechnology CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 36. Agilent Technologies Corporate Summary
Table 37. Agilent Technologies CRISPR Gene Testing and Diagnostics Product Offerings
Table 38. Agilent Technologies CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 39. Axxam Corporate Summary
Table 40. Axxam CRISPR Gene Testing and Diagnostics Product Offerings
Table 41. Axxam CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 42. Beckman Coulter Corporate Summary
Table 43. Beckman Coulter CRISPR Gene Testing and Diagnostics Product Offerings
Table 44. Beckman Coulter CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 45. Becton, Dickinson and Company Corporate Summary
Table 46. Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Product Offerings
Table 47. Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 48. Binx Health Corporate Summary
Table 49. Binx Health CRISPR Gene Testing and Diagnostics Product Offerings
Table 50. Binx Health CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 51. bioM?rieux Corporate Summary
Table 52. bioM?rieux CRISPR Gene Testing and Diagnostics Product Offerings
Table 53. bioM?rieux CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 54. Bio-Rad Laboratories Corporate Summary
Table 55. Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Product Offerings
Table 56. Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 57. Caspr Biotech Corporate Summary
Table 58. Caspr Biotech CRISPR Gene Testing and Diagnostics Product Offerings
Table 59. Caspr Biotech CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 60. ERS Genomics Corporate Summary
Table 61. ERS Genomics CRISPR Gene Testing and Diagnostics Product Offerings
Table 62. ERS Genomics CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 63. FASMAC Corporate Summary
Table 64. FASMAC CRISPR Gene Testing and Diagnostics Product Offerings
Table 65. FASMAC CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 66. Illumina Corporate Summary
Table 67. Illumina CRISPR Gene Testing and Diagnostics Product Offerings
Table 68. Illumina CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 69. Janssen Diagnostics Corporate Summary
Table 70. Janssen Diagnostics CRISPR Gene Testing and Diagnostics Product Offerings
Table 71. Janssen Diagnostics CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 72. Locus Biosciences Corporate Summary
Table 73. Locus Biosciences CRISPR Gene Testing and Diagnostics Product Offerings
Table 74. Locus Biosciences CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 75. Mammoth Biosciences Corporate Summary
Table 76. Mammoth Biosciences CRISPR Gene Testing and Diagnostics Product Offerings
Table 77. Mammoth Biosciences CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 78. NRGene Corporate Summary
Table 79. NRGene CRISPR Gene Testing and Diagnostics Product Offerings
Table 80. NRGene CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 81. Roche Corporate Summary
Table 82. Roche CRISPR Gene Testing and Diagnostics Product Offerings
Table 83. Roche CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 84. Sherlock Biosciences Corporate Summary
Table 85. Sherlock Biosciences CRISPR Gene Testing and Diagnostics Product Offerings
Table 86. Sherlock Biosciences CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 87. Thermo Fisher Scientific Corporate Summary
Table 88. Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Product Offerings
Table 89. Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
Table 90. Vivlion Corporate Summary
Table 91. Vivlion CRISPR Gene Testing and Diagnostics Product Offerings
Table 92. Vivlion CRISPR Gene Testing and Diagnostics Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. CRISPR Gene Testing and Diagnostics Segment by Type in 2022
Figure 2. CRISPR Gene Testing and Diagnostics Segment by Application in 2022
Figure 3. Global CRISPR Gene Testing and Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CRISPR Gene Testing and Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global CRISPR Gene Testing and Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CRISPR Gene Testing and Diagnostics Revenue in 2022
Figure 8. By Type - Global CRISPR Gene Testing and Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global CRISPR Gene Testing and Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Region - Global CRISPR Gene Testing and Diagnostics Revenue Market Share, 2018-2030
Figure 11. By Country - North America CRISPR Gene Testing and Diagnostics Revenue Market Share, 2018-2030
Figure 12. US CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 13. Canada CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe CRISPR Gene Testing and Diagnostics Revenue Market Share, 2018-2030
Figure 16. Germany CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. France CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. Italy CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 20. Russia CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia CRISPR Gene Testing and Diagnostics Revenue Market Share, 2018-2030
Figure 24. China CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Japan CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 28. India CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America CRISPR Gene Testing and Diagnostics Revenue Market Share, 2018-2030
Figure 30. Brazil CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa CRISPR Gene Testing and Diagnostics Revenue Market Share, 2018-2030
Figure 33. Turkey CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 34. Israel CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. UAE CRISPR Gene Testing and Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 37. 10x Genomics CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Aelian Biotechnology CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Agilent Technologies CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Axxam CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Beckman Coulter CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Binx Health CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. bioM?rieux CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Caspr Biotech CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. ERS Genomics CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. FASMAC CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Illumina CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Janssen Diagnostics CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Locus Biosciences CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Mammoth Biosciences CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. NRGene CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Roche CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Sherlock Biosciences CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Vivlion CRISPR Gene Testing and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
